RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer

PURPOSE: Triple-negative breast cancer (TNBC) is highly malignant and has poor prognosis and a high mortality rate. The lack of effective therapy has spurred our investigation of new targets for treating this malignant cancer. Here, we identified RON (macrophage-stimulating 1 receptor) and MET (MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Tian-Hao, Yao, Min-Ya, Xu, Xiang-Ming, Hu, Chen-Yu, Yao, Shu-Hao, Liu, Yi-Zhi, Wu, Zhi-Gang, Tang, Tao-Ming, Fu, Pei-Fen, Wang, Ming-Hai, Yao, Hang-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373856/
https://www.ncbi.nlm.nih.gov/pubmed/32324988
http://dx.doi.org/10.4143/crt.2019.726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373856/
https://www.ncbi.nlm.nih.gov/pubmed/32324988
http://dx.doi.org/10.4143/crt.2019.726

Ejemplares similares